Tysabri
Wednesday, June 1st, 2005Tysabri, a multiple sclerosis drug given by infusion, has now been linked to three cases of progressive multifocal leukoencephalopathy, or PML. The two original patients who developed PML were taking the drug Avonex at the same time they took Tysabri to treat the symptoms of multiple sclerosis. The third patient was discovered to have PML in an autopsy, after originally being misdiagnosed as having a brain tumor. It was announced in March 2005 that this patient was taking Tysabri to treat Crohn’s disease, and was not taking Avonex. Tysabri was pulled from the market in February of 2005.
Long distance calling cards – Prepaid phone cards online shop.
Free Web Templates, Professional WordPress Themes, Free Joomla Templates and more.
Network monitoring, computer and employee monitoring software.
Miriads.info – Export Import B2B Marketplace International trade opportunities. Business offers, Company listings, effective Advertising for business people, Free trade leads.
